-$0.37 EPS Expected for Senesco Technologies Inc. (NYSE:ELOX) This Quarter

Wall Street brokerages expect Senesco Technologies Inc. (NYSE:ELOX) to post earnings of ($0.37) per share for the current quarter, according to Zacks. Zero analysts have issued estimates for Senesco Technologies’ earnings, with the lowest EPS estimate coming in at ($0.48) and the highest estimate coming in at ($0.27). Senesco Technologies reported earnings per share of ($0.28) in the same quarter last year, which suggests a negative year-over-year growth rate of 32.1%. The business is scheduled to report its next quarterly earnings results on Friday, March 13th.

On average, analysts expect that Senesco Technologies will report full year earnings of ($1.45) per share for the current financial year, with EPS estimates ranging from ($1.65) to ($1.32). For the next fiscal year, analysts expect that the company will post earnings of ($1.46) per share, with EPS estimates ranging from ($1.62) to ($1.29). Zacks’ EPS averages are a mean average based on a survey of research firms that cover Senesco Technologies.

Shares of ELOX stock traded up $0.16 on Tuesday, hitting $4.22. 112,900 shares of the stock were exchanged, compared to its average volume of 91,259. Senesco Technologies has a one year low of $2.87 and a one year high of $17.50. The firm’s 50 day moving average is $4.33 and its two-hundred day moving average is $7.54.

About Senesco Technologies

Eloxx Pharmaceuticals, Inc, a clinical-stage biopharmaceutical company, focuses on discovering and developing novel therapeutics for the treatment of rare and ultra-rare premature stop codon diseases. Its lead program is ELX-02, which is in Phase I clinical trial, which focuses on the treatment of cystic fibrosis and cystinosis patients with diagnosed nonsense mutations.

See Also: Profit margin is different from the revenue

Get a free copy of the Zacks research report on Senesco Technologies (ELOX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Senesco Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senesco Technologies and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit